Literature DB >> 24412271

Mechanisms of homologous and heterologous phosphorylation of FFA receptor 4 (GPR120): GRK6 and PKC mediate phosphorylation of Thr³⁴⁷, Ser³⁵⁰, and Ser³⁵⁷ in the C-terminal tail.

Rebecca N Burns1, Monalisa Singh1, Ilya S Senatorov1, Nader H Moniri2.   

Abstract

Free fatty acid receptor 4 (FFA4), previously known as GPR120, is a G protein-coupled receptor that promotes numerous anti-inflammatory and antidiabetic effects upon its agonism by long chained unsaturated fatty acids. We have previously demonstrated that agonism of FFA4 with docosahexaenoic acid (DHA) and alpha-linoleic acid (ALA) facilitates rapid and transient phosphorylation of FFA4 expressed ectopically on the surface of HEK293 cells. However, the precise mechanisms that promote FFA4 phosphorylation remain elusive. In the current study, we examined the mechanisms behind both heterologous and homologous phosphorylation of FFA4 and set out to identify the foci of FFA4 phosphorylation. Our results demonstrate that basal and heterologous phosphorylation of FFA4 are mediated by protein kinase C (PKC), while G protein-coupled receptor kinase 6 (GRK6) plays the predominant role in DHA-mediated phosphorylation of FFA4. Furthermore, we identify Thr(347), Ser(350), and Ser(357) in the C-terminal tail as major sites of FFA4 phosphorylation. Concurrent mutation of these three sites leads to a FFA4 receptor that seemingly affects Gαq/11 signaling in a positive manner as demonstrated by heightened intracellular Ca(2+) responses following agonism with DHA. Importantly, this phosphodefective FFA4 mutant lacked the ability to promote β-arrestin-2 recruitment to the cell membrane. Since many of the functionally beneficial physiological effects of FFA4 are noted to be β-arrestin mediated, these findings could provide insight into the structural requirements for FFA4 function.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Free-fatty acid; G-protein; GPCR; Receptor; Signaling

Mesh:

Substances:

Year:  2014        PMID: 24412271      PMCID: PMC3959902          DOI: 10.1016/j.bcp.2013.12.016

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  31 in total

Review 1.  Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling.

Authors:  S S Ferguson
Journal:  Pharmacol Rev       Date:  2001-03       Impact factor: 25.468

Review 2.  Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization.

Authors:  Trudy A Kohout; Robert J Lefkowitz
Journal:  Mol Pharmacol       Date:  2003-01       Impact factor: 4.436

Review 3.  Seven-transmembrane receptors.

Authors:  Kristen L Pierce; Richard T Premont; Robert J Lefkowitz
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

4.  Multiple kinases phosphorylate the pancreatic cholecystokinin receptor in an agonist-dependent manner.

Authors:  L K Gates; C D Ulrich; L J Miller
Journal:  Am J Physiol       Date:  1993-05

5.  Expression, purification, and characterization of the G protein-coupled receptor kinase GRK6.

Authors:  R P Loudon; J L Benovic
Journal:  J Biol Chem       Date:  1994-09-09       Impact factor: 5.157

6.  Modulation of NMDA-mediated excitotoxicity by protein kinase C.

Authors:  R Wagey; J Hu; S L Pelech; L A Raymond; C Krieger
Journal:  J Neurochem       Date:  2001-08       Impact factor: 5.372

7.  Postprandial inhibition of gastric ghrelin secretion by long-chain fatty acid through GPR120 in isolated gastric ghrelin cells and mice.

Authors:  Xinping Lu; Xilin Zhao; Jianying Feng; Alice P Liou; Shari Anthony; Susanne Pechhold; Yuxiang Sun; Huiyan Lu; Stephen Wank
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-07       Impact factor: 4.052

8.  Rapid agonist-mediated phosphorylation of m3-muscarinic receptors revealed by immunoprecipitation.

Authors:  A B Tobin; S R Nahorski
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

9.  Protein kinase C(mu) regulation of the JNK pathway is triggered via phosphoinositide-dependent kinase 1 and protein kinase C(epsilon).

Authors:  Ilona Brändlin; Tim Eiseler; Rüdiger Salowsky; Franz-Josef Johannes
Journal:  J Biol Chem       Date:  2002-09-09       Impact factor: 5.157

10.  Truncation of the receptor carboxyl terminus impairs agonist-dependent phosphorylation and desensitization of the alpha 1B-adrenergic receptor.

Authors:  A L Lattion; D Diviani; S Cotecchia
Journal:  J Biol Chem       Date:  1994-09-09       Impact factor: 5.157

View more
  20 in total

Review 1.  G protein-coupled receptors as targets for anti-diabetic therapeutics.

Authors:  Da Young Oh; Jerrold M Olefsky
Journal:  Nat Rev Drug Discov       Date:  2016-01-29       Impact factor: 84.694

2.  Fish oil and flax seed oil supplemented diets increase FFAR4 expression in the rat colon.

Authors:  Ameneh Cheshmehkani; Ilya S Senatorov; Praveen Kandi; Monalisa Singh; April Britt; Renee Hayslett; Nader H Moniri
Journal:  Inflamm Res       Date:  2015-08-15       Impact factor: 4.575

3.  Carboxy-Terminal Phosphoregulation of the Long Splice Isoform of Free-Fatty Acid Receptor-4 Mediates β-Arrestin Recruitment and Signaling to ERK1/2.

Authors:  Ilya S Senatorov; Ameneh Cheshmehkani; Rebecca N Burns; Kirti Singh; Nader H Moniri
Journal:  Mol Pharmacol       Date:  2020-03-04       Impact factor: 4.436

Review 4.  Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4.

Authors:  G Milligan; E Alvarez-Curto; K R Watterson; T Ulven; B D Hudson
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

5.  Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum.

Authors:  Neha Milind Chitre; Bo Jarrett Wood; Azizi Ray; Nader H Moniri; Kevin Sean Murnane
Journal:  Neuropharmacology       Date:  2020-01-27       Impact factor: 5.250

6.  Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites.

Authors:  Lawrence C Blume; Theresa Patten; Khalil Eldeeb; Sandra Leone-Kabler; Alexander A Ilyasov; Bradley M Keegan; Jeremy E O'Neal; Caroline E Bass; Roy R Hantgan; W Todd Lowther; Dana E Selley; A Llyn C Howlett
Journal:  Mol Pharmacol       Date:  2016-11-28       Impact factor: 4.436

7.  Spatiotemporal dynamic monitoring of fatty acid-receptor interaction on single living cells by multiplexed Raman imaging.

Authors:  Wei Zhang; Fangjun Lin; Yan Liu; Han Zhang; Timothy A Gilbertson; Anhong Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-03       Impact factor: 11.205

8.  Free-fatty acid receptor-4 (FFA4) modulates ROS generation and COX-2 expression via the C-terminal β-arrestin phosphosensor in Raw 264.7 macrophages.

Authors:  Ameneh Cheshmehkani; Ilya S Senatorov; Jyothi Dhuguru; Ola Ghoneim; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2017-09-21       Impact factor: 5.858

9.  Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells.

Authors:  Ze Liu; Mandi M Hopkins; Zhihong Zhang; Chrystal B Quisenberry; Louise C Fix; Brianna M Galvan; Kathryn E Meier
Journal:  J Pharmacol Exp Ther       Date:  2014-12-09       Impact factor: 4.030

Review 10.  The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines.

Authors:  Ilya S Senatorov; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2018-02-13       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.